Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia
Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines made from a person's white blood cells and cancer cells may make the body
build an effective immune response to kill cancer cells.
PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in
treating patients with acute myeloid leukemia.